House of Commons · Written Ministerial Statement
UK wide Commercial Research Delivery Centres funded to support the health and wealth of the nation through research
12 December 2024 · Department of Health and Social Care
Proposed by Andrew Gwynne Ind Gorton and Denton
Summarised by AI from the official record, so it can contain mistakes.
At a glance
Key points
- The UK government has established 20 new Commercial Research Delivery Centres (CRDCs) to support health and economic benefits.
- The CRDCs are funded by the Voluntary scheme for branded medicines Pricing, Access and Growth (VPAG) Investment Programme and the National Institute for Health and Care Research (NIHR).
- The initiative aims to expand commercial clinical research capabilities and enhance access to new treatments through improved trial processes.
Issue summary
The statement announces the establishment of 20 new Commercial Research Delivery Centres (CRDCs) funded by the Voluntary scheme for branded medicines Pricing, Access and Growth (VPAG) Investment Programme and the National Institute for Health and Care Research (NIHR).
Action requested
The funding will support the expansion of commercial clinical research capabilities across the UK, enhancing access to new treatments through streamlined trial processes in various healthcare settings. This programme aims to boost economic growth and global competitiveness in life sciences.
Key facts
- The CRDC programme is funded by the VPAG Investment Programme and the National Institute for Health and Care Research (NIHR).
- Funding will be allocated to NHS organisations across all four UK nations.
- The network of CRDCs covers various locations including Sussex, Aberdeen, Wales, and Northern Ireland.
- The CRDCs aim to enhance UK competitiveness in global health research by facilitating access to new medicines and vaccines through clinical trials.